Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Jan 14, 2013; 19(2): 290-298
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.290
Published online Jan 14, 2013. doi: 10.3748/wjg.v19.i2.290
IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients
Mostafa K El Awady, Noha G Bader El Din, Ashraf Tabll, Tawfeek H Abdelhafez, Department of Microbial Biotechnology, National Research Center, Cairo, Giza 12622, Egypt
Yaser El Hosary, Department of Internal Medicin, National Research Center, Cairo, Giza 12622, Egypt
Ashraf O Abdel Aziz, Department of Tropical Medicine, Cairo University, Giza 12622, Egypt
Hesham El Khayat, Theodor Bilharz Research Institute, Giza 12622, Egypt
Mohsen Salama, National Liver Institute, Shebeen El Kom 32512, Egypt
Author contributions: El Awady MK designed the experiment, designed the new primers, and wrote the manuscript; Bader El Din NG, performed research work (IL28 PCR, CMV PCR, HCV PCR), edited the manuscript and made the final revision; Tabll A helped in the manuscript writing; El Hosary Y, Abdet Aziz AO, El Khayat H, Salama M provided blood samples; Abdelhafez TH participated in designing the new primers, and performed research work (IL28 PCR).
Supported by Misr El-Khair Foundation, Cairo, Egypt
Correspondence to: Dr. Mostafa El Awady, PhD, Department of Microbial Biotechnology, National Research Center, El-Behooth Street 12622, Dokki, Cairo, Giza 12622, Egypt. mkawady@yahoo.com
Telephone: +20-12-3132640 Fax: +20-2-3370931
Received: January 14, 2012
Revised: April 28, 2012
Accepted: May 5, 2012
Published online: January 14, 2013
Revised: April 28, 2012
Accepted: May 5, 2012
Published online: January 14, 2013
Core Tip